Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors

Breast Cancer Research and Treatment

Volumn 124, Issue 1, 2010, Pages 205-211

  Su, H Irene ^c   Sammel, Mary D ^a   Springer, Erin ^a   Freeman, Ellen W ^a   Demichele, Angela ^a,b   Mao, Jun J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NONE

Author keywords

Aromatase inhibitor; Body size; Breast cancer; Hot flash; Weight

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; EXEMESTANE; LETROZOLE; TAMOXIFEN;

ADULT; AGED; ANXIETY; ARTICLE; BODY HEIGHT; BODY MASS; BODY SIZE; BODY WEIGHT; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVOR; CAUCASIAN; DEPRESSION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HOT FLUSH; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; SMOKING; TREATMENT DURATION; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HOT FLASHES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; OUTPATIENTS; PHILADELPHIA; POSTMENOPAUSE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 77957716246     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0802-6     Document Type: Article

References (25)

1. JS Carpenter MA Andrykowski M Cordova L Cunningham J Studts P McGrath D Kenady D Sloan R Munn 1998 Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life Cancer 82 1682 1691 1:STN:280:DyaK1c3jsFyhsA%3D%3D 10.1002/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.0.CO;2-0 9576289
2. RJ Couzi KJ Helzlsouer JH Fetting 1995 Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy J Clin Oncol 13 2737 2744 1:STN:280:DyaK28%2Fmslagsw%3D%3D 7595732
3. JS Carpenter MA Andrykowski 1999 Menopausal symptoms in breast cancer survivors Oncol Nurs Forum 26 1311 1317 1:STN:280:DyaK1MvislChsg%3D%3D 10497770
4. G Finck DL Barton CL Loprinzi SK Quella JA Sloan 1998 Definitions of hot flashes in breast cancer survivors J Pain Symptom Manage 16 327 333 1:STN:280:DyaK1M%2Fmt1Cmug%3D%3D 10.1016/S0885-3924(98)00090-6 9846028
5. PF Harris PL Remington A Trentham-Dietz CI Allen PA Newcomb 2002 Prevalence and treatment of menopausal symptoms among breast cancer survivors J Pain Symptom Manage 23 501 509 10.1016/S0885-3924(02)00395-0 12067774
6. KD Stein PB Jacobsen DM Hann H Greenberg G Lyman 2000 Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer J Pain Symptom Manage 19 436 445 1:STN:280:DC%2BD3cvivFWgug%3D%3D 10.1016/S0885-3924(00)00142-1 10908824
7. JS Carpenter D Johnson L Wagner M Andrykowski 2002 Hot flashes and related outcomes in breast cancer survivors and matched comparison women Oncol Nurs Forum 29 E16 E25 10.1188/02.ONF.E16-E25 11979290
8. MJ Mourits EG De Vries PH Willemse KA Ten Hoor H Hollema AG Van der Zee 2001 Tamoxifen treatment and gynecologic side effects: a review Obstet Gynecol 97 855 866 1:CAS:528:DC%2BD3MXjtFGjsLs%3D 10.1016/S0029-7844(00)01196-0 11336777
9. PE Goss JN Ingle S Martino NJ Robert HB Muss MJ Piccart M Castiglione D Tu LE Shepherd KI Pritchard RB Livingston NE Davidson L Norton EA Perez JS Abrams P Therasse MJ Palmer JL Pater 2003 A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer N Engl J Med 349 1793 1802 1:CAS:528:DC%2BD3sXosl2gtbc%3D 10.1056/NEJMoa032312 14551341
10. L Fallowfield D Cella J Cuzick S Francis G Locker A Howell 2004 Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (atac) adjuvant breast cancer trial J Clin Oncol 22 4261 4271 1:CAS:528:DC%2BD2cXhtVKju7bF 10.1200/JCO.2004.08.029 15514369
11. J Cuzick I Sestak D Cella L Fallowfield 2008 Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial Lancet Oncol 9 1143 1148 1:CAS:528:DC%2BD1cXhsVWrsL7J 10.1016/S1470-2045(08)70259-6 18976959
12. EW Freeman MD Sammel JA Grisso M Battistini B Garcia-Espagna L Hollander 2001 Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women J Womens Health Gend Based Med 10 67 76 1:STN:280:DC%2BD3MvkslWksg%3D%3D 10.1089/152460901750067133 11224946
13. EW Freeman MD Sammel H Lin CR Gracia S Kapoor T Ferdousi 2005 The role of anxiety and hormonal changes in menopausal hot flashes Menopause 12 258 266 10.1097/01.GME.0000142440.49698.B7 15879914
14. EB Gold B Sternfeld JL Kelsey C Brown C Mouton N Reame L Salamone R Stellato 2000 Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age Am J Epidemiol 152 463 473 1:STN:280:DC%2BD3cvktFehuw%3D%3D 10.1093/aje/152.5.463 10981461
15. JR Guthrie L Dennerstein JL Hopper HG Burger 1996 Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women Obstet Gynecol 88 437 442 1:CAS:528:DyaK28XlvVGls7g%3D 10.1016/0029-7844(96)00196-2 8752255
16. I Overlie MH Moen A Holte A Finset 2002 Androgens and estrogens in relation to hot flushes during the menopausal transition Maturitas 41 69 77 1:CAS:528:DC%2BD38XmsFGgug%3D%3D 10.1016/S0378-5122(01)00256-0 11809345
17. MK Whiteman CA Staropoli PW Langenberg RJ McCarter KH Kjerulff JA Flaws 2003 Smoking, body mass, and hot flashes in midlife women Obstet Gynecol 101 264 272 10.1016/S0029-7844(02)02593-0 12576249
18. JA Sloan CL Loprinzi PJ Novotny DL Barton BI Lavasseur H Windschitl 2001 Methodologic lessons learned from hot flash studies J Clin Oncol 19 4280 4290 1:STN:280:DC%2BD3MnosFWgtA%3D%3D 11731510
19. NF Santoro CL Dicken 2009 Hot flashes: a rose is a rose is a rose Menopause 16 432 433 10.1097/gme.0b013e3181a05dd1 19265723
20. EB Gold A Colvin N Avis J Bromberger GA Greendale L Powell B Sternfeld K Matthews 2006 Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation Am J Public Health 96 1226 1235 10.2105/AJPH.2005. 066936 16735636
21. JL Otte D Flockhart D Hayes AM Storniolo V Stearns B Schneider NL Henry F Azzouz A Nguyen S Lemler J Hayden S Jeter L Wright JS Carpenter 2009 Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy Menopause 16 653 659 10.1097/gme.0b013e3181a5d0d6 19455068
22. L Gallicchio K Visvanathan SR Miller J Babus LM Lewis H Zacur JA Flaws 2005 Body mass, estrogen levels, and hot flashes in midlife women Am J Obstet Gynecol 193 1353 1360 1:CAS:528:DC%2BD2MXhtVymsLzJ 10.1016/j.ajog.2005.04.001 16202725
23. RT Chlebowski E Aiello A McTiernan 2002 Weight loss in breast cancer patient management J Clin Oncol 20 1128 1143 10.1200/JCO.20.4.1128 11844838
24. LM Troy DJ Hunter JE Manson GA Colditz MJ Stampfer WC Willett 1995 The validity of recalled weight among younger women Int J Obes Relat Metab Disord 19 570 572 1:STN:280:DyaK28%2FitVertg%3D%3D 7489028
25. RC Thurston MR Sowers Y Chang B Sternfeld EB Gold JM Johnston KA Matthews 2008 Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation Am J Epidemiol 167 78 85 10.1093/aje/kwm244 17881385